Results 101 to 110 of about 424,058 (165)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Estimating the Public Health and Economic Impact of Annual mRNA COVID-19 Vaccination for Adults Aged 50 and Older in South Korea’s Endemic Era

Vaccines
Background/Objectives: COVID-19 continues to challenge public health due to emerging variants. To mitigate this, the Korea Disease Control and Prevention Agency (KDCA) recommends annual COVID-19 vaccination, but uptake remains suboptimal.
Jaehee Jung, Dain Lee, Hee-Do Yang, Ah-Young Kim, Haeun Lee, Minkyoung Kang, Ekkehard Beck, Keya Joshi, Youngju Kang, Hye-Young Kang   +9 more
doaj   +1 more source

Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults

Human Vaccines & Immunotherapeutics
A multicomponent vaccine against seasonal influenza and COVID-19 could reduce disease burden in adults by providing simultaneous protection in a single-dose regimen.
Amanda K. Rudman Spergel, Carole Henry, Raffael Nachbagauer, Paulina Kaplonek, Eleanor Astley, Andrei Avanesov, Harry Bertera, Lizbeth Carmona, Deniz Cizmeci, Avi Collins, Alan Embry, Ruiting Guo, Xuezhou Mao, Alicia Pucci, Sarah Shao, Jessica Shih-Lu-Lee, Wen-Han Yu, Daniel Brune, Laurence Chu, Muhammad Irfan, Galit Alter, Jintanat Ananworanich, Christine A. Shaw   +22 more
doaj   +1 more source

mRNA-1273/rituximab [PDF]

Reactions Weekly, 2021
openaire   +1 more source

mRNA-1273/tozinameran [PDF]

Reactions Weekly, 2022
openaire   +2 more sources

From discovery through emergency use to the present: Safety evaluation of the COVID-19 mRNA-1273 (Moderna) vaccine. [PDF]

Hum Vaccin Immunother
Straus W.
europepmc   +1 more source

Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]

J Clin Immunol
Kunc M, Whitehead BJ, Østergaard LJ, Tolstrup M, Benn CS, Wejse CM, Nejsum P.   +6 more
europepmc   +1 more source

Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial. [PDF]

Open Forum Infect Dis
Pfeiffer S, Rhee M, Striplin S, Urdaneta V, Straus W, Wang X, Girard B, Priddy F, Chalkias S.   +8 more
europepmc   +1 more source

IgG4 Neutralization and Sustained Total IgG Fc-Effector Functions Following Repeated SARS-CoV-2 Vaccination with mRNA-1273. [PDF]

Infect Dis Ther
Kaplonek P, Bertera H, Lee DW, Cizmeci D, Yu WH, Wu K, Chalkias S, Wahid R, Edwards D, Alter G, Henry C.   +10 more
europepmc   +1 more source

A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. [PDF]

Vaccines (Basel)
Bourdon PS, Duriseti R, Gromoll HC, Dalton DK, Bardosh K, Krug AE.   +5 more
europepmc   +1 more source